Cargando…

An aging-susceptible circadian rhythm controls cutaneous antiviral immunity

Aged skin is prone to viral infections, but the mechanisms responsible for this immunosenescent immune risk are unclear. We observed that aged murine and human skin expressed reduced levels of antiviral proteins (AVPs) and circadian regulators, including Bmal1 and Clock. Bmal1 and Clock were found t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchner, Stephen J., Lei, Vivian, Kim, Paul T., Patel, Meera, Shannon, Jessica L., Corcoran, David, Hughes, Dalton, Waters, Diana K., Dzirasa, Kafui, Erdmann, Detlev, Coers, Jörn, MacLeod, Amanda S., Zhang, Jennifer Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619492/
https://www.ncbi.nlm.nih.gov/pubmed/37725438
http://dx.doi.org/10.1172/jci.insight.171548
_version_ 1785130000029057024
author Kirchner, Stephen J.
Lei, Vivian
Kim, Paul T.
Patel, Meera
Shannon, Jessica L.
Corcoran, David
Hughes, Dalton
Waters, Diana K.
Dzirasa, Kafui
Erdmann, Detlev
Coers, Jörn
MacLeod, Amanda S.
Zhang, Jennifer Y.
author_facet Kirchner, Stephen J.
Lei, Vivian
Kim, Paul T.
Patel, Meera
Shannon, Jessica L.
Corcoran, David
Hughes, Dalton
Waters, Diana K.
Dzirasa, Kafui
Erdmann, Detlev
Coers, Jörn
MacLeod, Amanda S.
Zhang, Jennifer Y.
author_sort Kirchner, Stephen J.
collection PubMed
description Aged skin is prone to viral infections, but the mechanisms responsible for this immunosenescent immune risk are unclear. We observed that aged murine and human skin expressed reduced levels of antiviral proteins (AVPs) and circadian regulators, including Bmal1 and Clock. Bmal1 and Clock were found to control rhythmic AVP expression in skin, and such circadian control of AVPs was diminished by disruption of immune cell IL-27 signaling and deletion of Bmal1/Clock genes in mouse skin, as well as siRNA-mediated knockdown of CLOCK in human primary keratinocytes. We found that treatment with the circadian-enhancing agents nobiletin and SR8278 reduced infection of herpes simplex virus 1 in epidermal explants and human keratinocytes in a BMAL1/CLOCK-dependent manner. Circadian-enhancing treatment also reversed susceptibility of aging murine skin and human primary keratinocytes to viral infection. These findings reveal an evolutionarily conserved and age-sensitive circadian regulation of cutaneous antiviral immunity, underscoring circadian restoration as an antiviral strategy in aging populations.
format Online
Article
Text
id pubmed-10619492
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Clinical Investigation
record_format MEDLINE/PubMed
spelling pubmed-106194922023-11-02 An aging-susceptible circadian rhythm controls cutaneous antiviral immunity Kirchner, Stephen J. Lei, Vivian Kim, Paul T. Patel, Meera Shannon, Jessica L. Corcoran, David Hughes, Dalton Waters, Diana K. Dzirasa, Kafui Erdmann, Detlev Coers, Jörn MacLeod, Amanda S. Zhang, Jennifer Y. JCI Insight Research Article Aged skin is prone to viral infections, but the mechanisms responsible for this immunosenescent immune risk are unclear. We observed that aged murine and human skin expressed reduced levels of antiviral proteins (AVPs) and circadian regulators, including Bmal1 and Clock. Bmal1 and Clock were found to control rhythmic AVP expression in skin, and such circadian control of AVPs was diminished by disruption of immune cell IL-27 signaling and deletion of Bmal1/Clock genes in mouse skin, as well as siRNA-mediated knockdown of CLOCK in human primary keratinocytes. We found that treatment with the circadian-enhancing agents nobiletin and SR8278 reduced infection of herpes simplex virus 1 in epidermal explants and human keratinocytes in a BMAL1/CLOCK-dependent manner. Circadian-enhancing treatment also reversed susceptibility of aging murine skin and human primary keratinocytes to viral infection. These findings reveal an evolutionarily conserved and age-sensitive circadian regulation of cutaneous antiviral immunity, underscoring circadian restoration as an antiviral strategy in aging populations. American Society for Clinical Investigation 2023-10-23 /pmc/articles/PMC10619492/ /pubmed/37725438 http://dx.doi.org/10.1172/jci.insight.171548 Text en © 2023 Kirchner et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Kirchner, Stephen J.
Lei, Vivian
Kim, Paul T.
Patel, Meera
Shannon, Jessica L.
Corcoran, David
Hughes, Dalton
Waters, Diana K.
Dzirasa, Kafui
Erdmann, Detlev
Coers, Jörn
MacLeod, Amanda S.
Zhang, Jennifer Y.
An aging-susceptible circadian rhythm controls cutaneous antiviral immunity
title An aging-susceptible circadian rhythm controls cutaneous antiviral immunity
title_full An aging-susceptible circadian rhythm controls cutaneous antiviral immunity
title_fullStr An aging-susceptible circadian rhythm controls cutaneous antiviral immunity
title_full_unstemmed An aging-susceptible circadian rhythm controls cutaneous antiviral immunity
title_short An aging-susceptible circadian rhythm controls cutaneous antiviral immunity
title_sort aging-susceptible circadian rhythm controls cutaneous antiviral immunity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619492/
https://www.ncbi.nlm.nih.gov/pubmed/37725438
http://dx.doi.org/10.1172/jci.insight.171548
work_keys_str_mv AT kirchnerstephenj anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT leivivian anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT kimpault anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT patelmeera anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT shannonjessical anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT corcorandavid anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT hughesdalton anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT watersdianak anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT dzirasakafui anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT erdmanndetlev anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT coersjorn anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT macleodamandas anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT zhangjennifery anagingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT kirchnerstephenj agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT leivivian agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT kimpault agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT patelmeera agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT shannonjessical agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT corcorandavid agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT hughesdalton agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT watersdianak agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT dzirasakafui agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT erdmanndetlev agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT coersjorn agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT macleodamandas agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity
AT zhangjennifery agingsusceptiblecircadianrhythmcontrolscutaneousantiviralimmunity